dual agonist glp-1 glucagon Tirzepatide, a GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Survodutide Api Dual Glp-1 Glucagon
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5


00356-X/asset/fe33011b-ab13-4783-8b00-bc243449d31b/main.assets/gr2_lrg.jpg)



.png?w=1280&max-h=720&fit=crop&auto=format)













